Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using a hand-held pupillometer to quantify pupil constriction as part of the accommodation reflex.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Journal of neurology·2026
Same author

Men's health research priorities in men with multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2026
Same author

Effects of prism adaptation combined with electrical stimulation on cortical excitability of upper and lower limb muscles.

Behavioural brain research·2026
Same author

Use of semaglutide and tirzepatide among people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.

Neurorehabilitation and neural repair·2026
Same journal

Quantitative assessment of geniohyoid before and after rehabilitation in stroke patients with dysphagia by ultrasound.

Frontiers in rehabilitation sciences·2026
Same journal

Hidden in plain sight: personal factors in autism and ADHD - a protocol for extending the ICF Core Sets for autism and ADHD.

Frontiers in rehabilitation sciences·2026
Same journal

Multimodal rehabilitation in PLP1-associated spastic paraparesis: a case report with clinical and biomechanical outcomes.

Frontiers in rehabilitation sciences·2026
Same journal

Machine learning-based adaptive personalization in virtual reality stroke rehabilitation: a systematic review.

Frontiers in rehabilitation sciences·2026
Same journal

Reformation programmes in medium-security correctional facilities in Kwara State, Nigeria: evidence of functionality gaps.

Frontiers in rehabilitation sciences·2026
Same journal

Barriers and enablers to leadership advancement for women with disabilities: a systematic literature review.

Frontiers in rehabilitation sciences·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Stereoacuity Improvement using Random-Dot Video Games
06:25

Stereoacuity Improvement using Random-Dot Video Games

Published on: January 14, 2020

14.1K

Does prism adaptation treatment reduce spatial neglect and improve function?

Peii Chen1,2, Kimberly Hreha3, Catrina MacPhee4

  • 1Center for Stroke Rehabilitation Research, Kessler Foundation, West Orange, NJ, United States.

Frontiers in Rehabilitation Sciences
|February 21, 2025
PubMed
Summary
This summary is machine-generated.

Prism adaptation treatment (PAT) shows promise for spatial neglect (SN), but inconsistent evidence and lack of standardized protocols hinder its effectiveness. Further research is needed to optimize PAT for clinical use.

Keywords:
behavioral interventioneffectivenessefficacyrehabilitative therapysensorimotor adaptationspatial explorationtherapeutic treatmentunilateral spatial neglect

More Related Videos

Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
06:12

Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults

Published on: February 12, 2020

6.7K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

276

Related Experiment Videos

Last Updated: Jul 3, 2026

Stereoacuity Improvement using Random-Dot Video Games
06:25

Stereoacuity Improvement using Random-Dot Video Games

Published on: January 14, 2020

14.1K
Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
06:12

Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults

Published on: February 12, 2020

6.7K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

276

Area of Science:

  • Neuroscience
  • Rehabilitation Medicine
  • Clinical Psychology

Background:

  • Spatial neglect (SN) treatment effectiveness is debated due to inconsistent meta-analyses.
  • Clinical data suggests prism adaptation treatment (PAT) can reduce SN and improve function.

Purpose of the Study:

  • To critically review the evidence for PAT's therapeutic effects in SN.
  • To identify knowledge gaps and suggest future research directions.
  • To guide clinical decision-making regarding PAT.

Main Methods:

  • Utilized the NIH Stage Model for Behavioral Intervention Development framework.
  • Critically reviewed existing literature on prism adaptation treatment for spatial neglect.
  • Analyzed studies based on NIH model's emphasis on mechanisms, adaptability, and feasibility.

Main Results:

  • The NIH Stage Model highlighted heterogeneity in PAT studies and challenges in its advancement.
  • Key treatment parameters like prism strength, intensity, and evaluation methods lack consensus.
  • Significant variability exists in how PAT is applied and assessed across studies.

Conclusions:

  • Further research is essential to determine critical mechanisms and establish an optimal PAT protocol.
  • Consensus on treatment parameters and evaluation methods is needed before conducting new meta-analyses.
  • Standardizing PAT protocols is crucial for advancing its clinical efficacy and implementation.